Welcome
| Company Name | Product Name | Archive types | Announcement | View PDF | DIN # |
|---|---|---|---|---|---|
| Pharmascience | pms-SOLIFENACIN | Product Availability | Disponibilité des produits | We are pleased to announce the back in stock of the following products: pms-SOLIFENACIN 5mg 30`s & 100`s & 10mg 100`s |  | 2417723 |
| Pharmascience | pms-SOFLAX 100mg CAPS 100 | Discontinuation | Abandon de produit | After careful consideration of our product portfolio, the decision has been made to cease production of SOFLAX 100mg CAPS 100 for the Canadian market effective immediately. Thes product will be removed from our product catalogue. |  | 1994344 |
| Pharmascience | pms-DOCUSATE SODIUM 100mg CAPS 100 | Discontinuation | Abandon de produit | After careful consideration of our product portfolio, the decision has been made to cease production of pms-DOCUSATE SODIUM 100mg CAPS 100 for the Canadian market effective immediately. Thes product will be removed from our product catalogue. Please accept our sincere apologies for any inconvenience that this may cause. |  | 703494 |
| Pharmascience | pms-QUINAPRIL 10-20mg 100 | Product Availability | Disponibilité des produits | Pharmascience Canada is please to announced that pms-QUINAPRIL 10MG & 20MG TABS 100 are now back in stock and you may place your order now |  | 02340569 |
| Pharmascience | pms-LEVODOPA CARBIDOPA | New Product | Nouveau produit | We are pleased to announce the launch of pms-LEVODOPA CARBIDOPA IR! |  | 02549719 |
| Pharmascience | pms-FLUTICASONE HFA 50mcg | Product Availability | Disponibilité des produits | We are pleased to announce that pms-FLUTICASONE 50mcg is NOW AVAILABLE! |  | 02503115 |
| Pharmascience | pms-RIVAROXABAN 15mg TABS 3500 | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following product: pms-RIVAROXABAN 15mg TABS 3500, you may place your order now. |  | 2512068 |
| Pharmascience | pms-NITROFURANTOIN BID 100mg CAPS 100 | Product Availability | Disponibilité des produits | Pharmascience Canada is proud to announce that pms-NITROFURANTOIN BID 100mg CAPS 100 are back in stock and now available to order. |  | 2455676 |
| Sandoz | Sandoz Enalapril & Sandoz Risperidone | Discontinuation | Abandon de produit | Sandoz Canada wishes to inform you that the Sandoz Enalapril and Sandoz Risperidone will be no longer available upon depletion of inventory. |  | 00000 |
| Pharmascience | pms-DOXYLAMINE PYRIDOXINE 10/10mg T 500 | Product Availability | Disponibilité des produits | Pharmascience Canada is proud to announce that pms-DOXYLAMINE PYRIDOXINE 10/10mg T 500 are back in stock and now available to order. |  | 2406187 |
| Pharmascience | pms-AMLODIPINE 2.5mg TABS 500 | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following product: pms-AMLODIPINE 2.5mg TABS 500, you may place your order now. |  | 2295148 |
| Pharmascience | OLESTYR REG PWD ORANG FLV POUCH 30X4g | Product Availability | Disponibilité des produits | Pharmascience Canada is proud to announce that OLESTYR REG PWD ORANG FLV POUCH 30X4g are back in stock and now available to order. |  | 02210320 |
| Pharmascience | pms-VALACYCLOVIR 500mg CAPS 500 | New Product | Nouveau produit | Hello all, We are pleased to announce the launch of our 24th XL Format product, pms-VALACYCLOVIR 500mg CAPS 500. |  | 02298457 |
| Pharmascience | RUPATADINE | New Product | Nouveau produit | Pharmascience is pleased to announce the launch of pms-RUPATADINE! |  | 02552604 |
| Pharmascience | Octasa 800mg | Product Availability | Disponibilité des produits | Lower the pill burden for your patients suffering from ulcerative colitis with OCTASA® 800 mg |  | 02465752 |
| Sandoz | Zolmitriptan FCT and Zolmitriptan ODT | Product Availability | Disponibilité des produits | Sandoz Canada wishes to inform you that the following products will be unavailable for an indefinite period of time upon depletion of inventory. |  | |
| Pharmascience | pms-Sitagliptin | New Product | Nouveau produit | We are pleased to announce the launch of pms-SITAGLIPTIN! |  | 02503840 |
| Sandoz | Rivastigmine capsules | Discontinuation | Abandon de produit | Sandoz Canada wishes to inform you that Sandoz Rivastigmine capsules will be no longer available upon depletion of inventory. |  | 00000 |
| Pharmascience | Duloxetine 30mg 1000 CAPS | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following products: pms-DULOXETINE 30mg CAPS 1000, you may place your order now. |  | 2429446 |
| Pharmascience | Palbociclib | New Product | Nouveau produit | New product launch of pms-Palbociclib. |  | 02552132 |
| Pharmascience | pms-DULOXETINE 60mg CAPS 500 | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following product: pms-DULOXETINE 60mg CAPS 500, you may place your order now. |  | 2429454 |
| Sandoz | Alendronate, Dimethyl Fumarate, Finasteride | Discontinuation | Abandon de produit | Sandoz Canada wishes to inform you that the following products will be no longer available upon depletion of inventory. |  | 0000000 |
| Pharmascience | pms-DAPAGLIFLOZIN | Product Appearance Up date | Nouvel aspect du produit | We would like to inform you of the change in appearance of pms-DAPAGLIFOZIN 5MG & 10MG. Please take a few minutes to review the information below. |  | 02531550 |
| Sandoz | Sandoz Bilastine | New Product | Nouveau produit | We are glad to share the launch of PrSandoz® Bilastine |  | 02536269 |
| Sandoz | Pr SANDOZ® FESOTERODINE FUMARATE | Product Availability | Disponibilité des produits | Sandoz Canada wishes to inform you that the following product Pr SANDOZ® FESOTERODINE FUMARATE 8 MG 100 TABLETS will be unavailable for an indefinite period of time. Rest assured; we are doing our utmost to ensure the continuity of supply of the replacement product Pr Sandoz® Fesoterodine fumarate 8mg in bottles of 30 tablets. |  | 02521776 |
| Pharmascience | PERIOSTAT | Product Transition | Transition dans la production | We are pleased to announce the commercial transfer of PERIOSTAT 20mg Capsules from Pendopharm to Pharmascience Canada effective October 15th, 2024. |  | 02247104 |
| Sandoz | Sandoz AFAtinib | New Product | Nouveau produit | We are glad to share the launch of PrSandoz® AFAtinib. |  | 02512777 |
| Pharmascience | pms-GABAPENTIN 100mg CAPS 1000 | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following product: pms-GABAPENTIN 100mg CAPS 1000, you may place your order now. |  | 02243446 |
| Pharmascience | PMS-AMLODIPINE | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following products: pms-AMLODIPINE 5mg TABS 2000 / 10mg TABS 1000, you may place your order now. |  | 2284065 |
| Pharmascience | None Selected | ||||
| Pharmascience | PMS-CLONAZEPAM-R | Product Transition | Transition dans la production | Dear Customer, Pharmascience is pleased to announce the product change of PMS-CLONAZEPAM to PMS-CLONAZEPAM-R. |  | 02048701 |
| Pharmascience | pms-Escitalopram 10mg | Product Availability | Disponibilité des produits | We would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-Escitalopram 10mg blisters. Consequently we will be out of stock for an extended period of time |  | 02469243 |
| Pharmascience | pms-ROSUVASTATIN 20mg TABS 1500 | New pack size | Nouveau format | Dear Customer, Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-ROSUVASTATIN 20mg TABS 1500. |  | 02378558 |
| Sandoz | Multiple Products | Discontinuation | Abandon de produit | Discontinuation Notice Multiple products | ||
| Pharmascience | New pack size | Nouveau format | Dear Customer, Pharmascience Canada is please to announced the relaunch of the following products: pms-DEFERASIROX (TYPE J) 90mg, 180mg and 360mg TABS 30 BTL, are now available and you may place your order now. |  | 2528290 | |
| Sandoz | PrSandoz® Dutasteride | New Product | Nouveau produit | We’re glad to share the return of PrSandoz® Dutasteride 0.5 mg available in blister packs of 30 and bottles of 100 capsules. |  | 02424444 |
| Sandoz | Sandoz® Desvenlafaxine | New Product | Nouveau produit | We’re glad to share the launch of Sandoz® Desvenlafaxine. |  | 02538415 |
| Sandoz | Sandoz Rivastigmine Patch | Information Update | Mise à jour des renseignements | Sandoz Canada wishes to inform you that a downloadable tool is available for your patients who take Sandoz® Rivastigmine Patch. The tool is a multiple-page digital patient diary (one page per week) that can be printed out. It contains instructions for administering PrSandoz® Rivastigmine Patch and a place to record their use. |  | 02426293 |
| Sandoz | Sandoz® Bisoprolol | New Product | Nouveau produit | Sandoz® Bisoprolol new strengths. We're glad to share the launch of Sandoz® Bisoprolol 1.25 mg and 2.5 mg. • NEW CONCENTRATIONS exclusive to Sandoz 1.25 mg and 2.5 mg. • Scored tablets in 2.5 mg, 5 mg and 10 mg strengths. • Concentrations clearly indicated on tablets. • All strengths available in bottles of 100 tablets. |  | 02544245 |
| Sandoz | Sandoz Lisdexamfetamine | New Product | Nouveau produit | We are glad to share the launch of Sandoz® Lisdexamfetamine. |  | 02546248 |
| Pharmascience | pms-TRAZODONE | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following product: pms-TRAZODONE 50mg TABS 1500, you may place your order now. |  | 01937227 |
| Sandoz | Sandoz® Gliclazide MR and Sandoz® Pravastatin | Discontinuation | Abandon de produit | Discontinuation Notice Sandoz Canada wishes to inform you that we are discontinuing Sandoz® Gliclazide MR and Sandoz® Pravastatin. The products will be no longer available upon depletion of inventory (date communicated below is subjected to change). Please accept our apologies for any inconvenience this may cause. |  | 02461323 |
| Sandoz | Sandoz Docusate Sodium | Discontinuation | Abandon de produit | Discontinuation Notice Sandoz® Docusate Sodium |  | |
| Pharmascience | pms-PERINDOPRIL 8mg | New pack size | Nouveau format | Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-PERINDOPRIL 8mg TABS 1000. |  | 02470691 |
| Pharmascience | pms-FLUOXETINE 20mg CAPS | New pack size | Nouveau format | Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-FLUOXETINE 20MG CAPS 1000 and is now available to order. |  | 02177587 |
| Pharmascience | PERICHLOR 0.12% ORAL RINSE | Important Announcement | Annonce importante | Effective June 1st, 2024, the following products will be transferred from Pendopharm, division of Pharmascience Inc. to Pharmascience Inc. |  | 02493160 |
| Pharmascience | None Selected | ||||
| Sandoz | None Selected | ||||
| Pharmascience | pms-ROSUVASTATIN 5mg TABS 3000 | New pack size | Nouveau format | Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-ROSUVASTATIN 5mg TABS 3000. | 02378523 | |
| Sandoz | Sandoz Gliclazide MR | Product Availability | Disponibilité des produits | See PDF |  | 02314177 |
| Sandoz | NYPOZI | New Product | Nouveau produit | NYPOZI (filgrastim) is now available! |  | 02520990 |
| Sandoz | NYPOZI - ZIEXTENZO | New Product | Nouveau produit | Now offering the complete G-CSF portfolio |  | 02520990 |
| Pharmascience | None Selected | ||||
| Pharmascience | pms-DICLOFENAC 1.5% SOL TOPI 60 mL | Product Availability | Disponibilité des produits | We would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-DICLOFENAC 1.5% SOL TOPI 60 mL. Consequently we will be out of stock for an extended period of time. |  | 02356783 |
| Pharmascience | pms-METHOTREXATE 50MG/ML | New Product | Nouveau produit | Pharmascience Canada is pleased to announce the launch of pms-METHOTREXATE 50MG/ML, you may place your order now. |  | 2539608 |
| Pharmascience | pms-PERINDOPRIL-AMLODIPINE | New Product | Nouveau produit | Pharmascience Canada is pleased to announce the launch of pms-PERINDOPRIL-AMLODIPINE, you may place your order now. |  | 02541696 |
| Pharmascience | pms-CITALOPRAM HBR 40mg TAB 1100, | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following product: pms-CITALOPRAM HBR 40mg TAB 1100, you may place your order now. |  | 02248011 |
| Sandoz | Sandoz Apremilast | New pack size | Nouveau format | Sandoz Apremilast Started Kit now available |  | 02529092 |
| Sandoz | Sandoz Omeprazole | Discontinuation | Abandon de produit | Discontinuation Notice Sandoz® Omeprazole 10 mg |  | 02296438 |
| Pharmascience | pms-PREGABALIN 150mg 800 | New pack size | Nouveau format | Dear Customer, Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-PREGABALIN 150mg CAPS 800 and you may place your order now. | 2359634 | |
| Pharmascience | pms-LACTULOSE-PHARMA 667mg/mL | Product Transition | Transition dans la production | Dear Customer, Pharmascience is pleased to announce the product change of pharma-LACTULOSE 667mg/mL 500mL to pms-LACTULOSE-PHARMA 667mg/mL 500mL and 1000mL, effective immediately. |  | 02247383 |
| Pharmascience | pms-QUINAPRIL 40mg TABS 100 | Product Availability | Disponibilité des produits | Dear client, Pharmascience Canada is pleased to announce that pms-QUINAPRIL 40mg TABS 100 is now back in stock and you may place your order now. |  | 02340585 |
| Pharmascience | SILDENAFIL 100mg | Product Transition | Transition dans la production | Pharmascience is pleased to announce the product change of SILDENAFIL 100mg TABS 30 to SILDENAFIL 100mg TABS BLI 1X 4, effective immediately. |  | 02317583 |
| Pharmascience | pms-TERAZOSIN 2mg TABS 100 | Product Appearance Up date | Nouvel aspect du produit | Dear Customer, We would like to inform you of the change in appearance of pms-TERAZOSIN 2mg tablets. This change is effective immediately. Please take a few minutes to review the information below. |  | 02243519 |
| Pharmascience | pms-LITHIUM CARBONATE 300mg CAPS 100 | Product Availability | Disponibilité des produits | Dear Customer, We would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-LITHIUM CARBONATE 300mg CAPS 100. Consequently we will be out of stock for an extended period of time. |  | 02216140 |
199 Bay Street #4000, Toronto,
ON M5L 1A9
In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Academy website (the “Website”), you (“You”) expressly agree to the following:
Review: MDBriefCase is pleased to consider the publication of Your Work on the Website. The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.
Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered. If posted, You will be identified as the author of the Work, or co-author if applicable.
Grant of Rights: As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats: (1) the exclusive right of first publication worldwide; (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications. The grant of rights survives termination or expiration of this Agreement.
Warranty: You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work. This warranty survives termination or expiration of this Agreement.
Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Academy website.
The Healthcare Leadership Academy welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished. When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.
Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.
Guest articles for the MDBriefCase Healthcare Leadership Academy may run between 500 and 1000 words.
MDBriefCase reserves the right to accept or reject any submission and the right to condition acceptance upon revision of material to conform to its criteria.
There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal websites, corporate websites and social media platforms.
Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement.
